Immunogenic compositions comprising silicified virus and methods of use
AssigneesPortland State University, Providence Health & Services - Oregon
InventorsKenneth M. Stedman, James R. Laidler, Keith Bahjat
Life of this patent
Estimating the term…
Loading patent…
AssigneesPortland State University, Providence Health & Services - Oregon
InventorsKenneth M. Stedman, James R. Laidler, Keith Bahjat
Estimating the term…
It is disclosed herein that viruses coated in silica retain infectivity and the capacity to induce an immune response in an infected host. In addition, silicified virus is remarkably resistant to desiccation. Provided herein are methods of inducing a virus-specific immune response in a subject by administering to the subject an effective amount of silicified virus or silicified virus particles. Methods of enhancing a virus-specific cell-mediated immune response (such as a T cell-mediated immune response) in a subject by administering to the subject a silicified virus or silicified virus particles are also described herein. Further provided are immunogenic compositions comprising silicified virus or silicified virus particles, such as compositions useful as vaccines. The immunogenic compositions include a pharmaceutically acceptable carrier and/or an adjuvant.
A method of inducing a virus-specific immune response in a subject, comprising administering to the subject an effective amount of silicified virus or silicified virus particles, thereby inducing a virus-specific immune response in the subject.
An immunogenic composition comprising (i) a silicified virus or silicified virus particles and (ii) a pharmaceutically acceptable carrier or an adjuvant, wherein the virus is vaccinia virus, a rotavirus, an adenovirus, an influenza virus, a lentivirus, a flavivirus, a hepatitis virus, a picornavirus or a coronavirus.
Dependencies are inferred from the claim text.